SCHEMBL29935531

SCHEMBL29935531

CCCCCCCC/C=C\CCCCCCCC(=O)OCCCOP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.63
▸ NR5A2 O00482 1/20 0.63
▸ NR5A1 Q13285 1/20 0.63
▸ ALDH1A1 P00352 1/20 0.62
▸ LMNA P02545 1/20 0.61
▸ ESR1 P03372 1/20 0.61
▸ ADORA3 P0DMS8 1/20 0.61
▸ CDC25A P30304 1/20 0.61
▸ AGTR1 P30556 1/20 0.61
▸ AKT1 P31749 1/20 0.61
▸ ADRA1A P35348 1/20 0.61
▸ KCNH2 Q12809 1/20 0.61
▸ MAPT P10636 1/20 0.61
▸ MEN1 O00255 1/20 0.56
▸ S1PR1 P21453 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ P2RY10 O00398 4/20 0.55
▸ GPR34 Q9UPC5 1/20 0.55
▸ RECQL P46063 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10937572 0.94 SMN1; SMN2 (0.64) SMN1; SMN2NR5A2NR5A1ALDH1A1LMNA
SCHEMBL7720034 0.94 SMN1; SMN2 (0.64) SMN1; SMN2NR5A2NR5A1ALDH1A1LMNA
SCHEMBL4240744 0.93 LMNA (0.71) SMN1; SMN2NR5A2NR5A1LMNAESR1
SCHEMBL15968278 0.93 LMNA (0.71) SMN1; SMN2NR5A2NR5A1LMNAESR1
SCHEMBL23188432 0.89 P2RY10 (0.68) P2RY10GPR34
SCHEMBL14669245 0.89 P2RY10 (0.68) P2RY10GPR34
SCHEMBL10415337 0.88 ALDH1A1 (0.61) SMN1; SMN2NR5A2NR5A1ALDH1A1LMNA
SCHEMBL28625743 0.88 ALDH1A1 (0.61) SMN1; SMN2NR5A2NR5A1ALDH1A1LMNA
SCHEMBL19821339 0.87 SMN1; SMN2 (0.68) SMN1; SMN2NR5A2NR5A1ALDH1A1MAPT
SCHEMBL30555700 0.87 SMN1; SMN2 (0.68) SMN1; SMN2NR5A2NR5A1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12263181-B2 Phospholipid compositions MACHAVERT PHARMACEUTICALS LLC (US) 2025-04-01 — — US disclosed
US-20220409641-A1 PHOSPHOLIPID COMPOSITIONS MACHAVERT PHARMACEUTICALS LLC (US) 2022-12-29 — — US disclosed
US-11433085-B2 Phospholipid compositions MACHAVERT PHARMACEUTICALS, LLC (US) 2022-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220409641-A1 PHOSPHOLIPID COMPOSITIONS PHOSPHO1, SGMS1, SGMS2 SMN1; SMN2 1802/4885NR5A2 4657/4885NR5A1 3689/4885
US-11433085-B2 Phospholipid compositions PHOSPHO1, SGMS1, SGMS2 SMN1; SMN2 1802/4885NR5A2 4657/4885NR5A1 3689/4885
US-12263181-B2 Phospholipid compositions PHOSPHO1, SGMS1, SGMS2 SMN1; SMN2 1802/4885NR5A2 4657/4885NR5A1 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback